PRESS RELEASE. Sciety’s Board of Directors has appointed Anna Sundin as the company’s new CEO. She succeeds one of Sciety’s founders, Andreas Lindblom, who will continue in an operational role as Managing Partner. Anna Sundin has 25 years of experience in the financial sector and joins Sciety from BearingPoint, where
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
INSIGHT. Obesity is one of the fastest-growing public health challenges of our time. More than a billion people are estimated to be living with the disease globally today, a number that is expected to keep rising. The consequences are significant for individuals, healthcare systems and society as a whole. At
INSIGHT. Cancer treatment has long focused on removing or destroying visible tumours, with limited ways to confirm whether all cancer cells were truly gone. Even after successful treatment, small numbers of cells can persist and later cause relapse. While liquid biopsy has been used in oncology for several years, recent
